Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
D062365:Aminobenzoates / Q000494:pharmacology; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001120:Arginine / Q000494:pharmacology; D001646:Bile; D055598:Chemical Phenomena; D002621:Chemistry; D002850:Chromatography, Gel; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008745:Methylation; D010958:Plasminogen / Q000494:pharmacology; D013237:Stereoisomerism; D013552:Swine
D062365:Aminobenzoates; D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents; D010958:Plasminogen; D001120:Arginine